Investor profile

UNC Health Ventures

Corporate venture fund of the UNC Health system, established in 2012 as Rex Health Ventures with about $10 million and a Triangle focus, and renamed UNC Health Ventures on 2026-08-18 with $125 million to invest over the next decade from reallocated capital reserves. Invests primarily at Series A and Series B across medtech, healthtech, and biotech, is geographically agnostic, and has backed 30 companies with 12 active as of the rebrand. Anita Watkins and John Perez are managing directors. Active Triangle holdings include 410 Medical, baebies, Phononic, and Pryon; Emergo Therapeutics is a prior investment.